Lower body mass index is an adverse prognostic marker in acute heart failure for both sexes with HFrEF and women with HFpEF, but is not prognostic in men with HFpEF.
Does body mass index have sex- and phenotype-specific prognostic implications in patients with acute heart failure?
The prognostic value of BMI in acute heart failure depends on both sex and heart failure phenotype, with lower BMI indicating adverse risk in HFrEF but not in men with HFpEF.
Absolute Event Rate: 0% vs 0%
The prognostic implications of BMI in AHF differ according to HF phenotype and sex. Lower BMI is a consistent adverse marker in HFrEF in both sexes and shows a borderline adverse association in women with HFpEF, whereas BMI is not prognostic in men with HFpEF. These findings highlight the importance of sex- and phenotype-specific interpretation of BMI in risk assessment.
Won et al. (Tue,) reported a other. Lower body mass index is an adverse prognostic marker in acute heart failure for both sexes with HFrEF and women with HFpEF, but is not prognostic in men with HFpEF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: